ロード中...
Synthetic glycolipid-based TLR4 antagonists negatively regulate TRIF-dependent TLR4 signalling in human macrophages
TLRs, including TLR4, play a crucial role in inflammatory-based diseases, and TLR4 has been identified as a therapeutic target for pharmacological intervention. In previous studies, we investigated the potential of FP7, a novel synthetic glycolipid active as a TLR4 antagonist, to inhibit haematopoie...
保存先:
| 出版年: | Innate Immun |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8054148/ https://ncbi.nlm.nih.gov/pubmed/33858242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17534259211005840 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|